Related Experiment Video
Updated: May 6, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Influenza-associated pediatric deaths in the United States, 2004-2012
Karen K Wong1, Seema Jain, Lenee Blanton
11600 Clifton Rd NE, MS E-03, Atlanta, GA 30329. vij4@cdc.gov.
Insights
Annual influenza can be fatal in children, even those without high-risk conditions. Early antiviral treatment and universal annual influenza vaccination are crucial for pediatric influenza prevention and management.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Public Health
Background:
- Annual influenza-associated deaths occur in children.
- This study examines pediatric influenza deaths from 2004-2005 to 2011-2012.
Purpose of the Study:
- To describe the epidemiology of influenza-associated pediatric deaths.
- To compare characteristics of children with and without high-risk medical conditions.
Main Methods:
- Collected data on pediatric deaths with laboratory-confirmed influenza from the Centers for Disease Control and Prevention.
- Utilized standard case report forms for demographic, medical, and clinical data.
- Compared outcomes for children with and without high-risk medical conditions.
Main Results:
- 830 pediatric influenza-associated deaths were reported between 2004-2012.
- 35% of deaths occurred before hospital admission.
- 43% of children with known medical history had no high-risk conditions; these children were more likely to die before admission or within 3 days of symptom onset.
Conclusions:
- Influenza is a significant threat to children, regardless of underlying health status.
- Annual influenza vaccination for all children is essential.
- Early antiviral treatment is recommended for hospitalized, severely ill, or high-risk children.
Background:
Influenza-associated deaths in children occur annually. We describe the epidemiology of influenza-associated pediatric deaths from the 2004-2005 through the 2011-2012 influenza seasons.
Methods:
Deaths in children <18 years of age with laboratory-confirmed influenza virus infection were reported to the Centers for Disease Control and Prevention by using a standard case report form to collect data on demographic characteristics, medical conditions, clinical course, and laboratory results. Characteristics of children with no high-risk medical conditions were compared with those of children with high-risk medical conditions.
Results:
From October 2004 through September 2012, 830 pediatric influenza-associated deaths were reported. The median age was 7 years (interquartile range: 1-12 years). Thirty-five percent of children died before hospital admission. Of 794 children with a known medical history, 43% had no high-risk medical conditions, 33% had neurologic disorders, and 12% had genetic or chromosomal disorders. Children without high-risk medical conditions were more likely to die before hospital admission (relative risk: 1.9; 95% confidence interval: 1.6-2.4) and within 3 days of symptom onset (relative risk: 1.6; 95% confidence interval: 1.3-2.0) than those with high-risk medical conditions.
Conclusions:
Influenza can be fatal in children with and without high-risk medical conditions. These findings highlight the importance of recommendations that all children should receive annual influenza vaccination to prevent influenza, and children who are hospitalized, who have severe illness, or who are at high risk of complications (age <2 years or with medical conditions) should receive antiviral treatment as early as possible.
Related Concept Videos
Influenza
Vaccinations
Pharmacokinetics in Pediatric Patients: Drug Excretion
Infectious Diseases and Their Occurrence

